Search results
Results from the WOW.Com Content Network
This is a list of products and services provided by Johnson & Johnson (J&J). ... Pulmonary hypertension therapies Uptravi [77] Opsumit [78] Veletri [79] Tracleer [80]
Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure in the arteries of the lungs. [7] Symptoms include shortness of breath, fainting, tiredness, chest pain, swelling of the legs, and a fast heartbeat. [7] [1] The condition may make it difficult to exercise. [7] Onset is typically gradual. [8]
A pulmonary artery wedge pressure being less than 15 mmHg (also measured by right heart catheterization) excludes post-capillary bed (in the veins distal to the capillary bed) pulmonary hypertension. Pulmonary arterial hypertension is a subgroup of pulmonary hypertension and is categorized as World Health Organization as group 1. [3]
The choice between the drugs is to a large degree determined by the characteristics of the patient being prescribed for, the drugs' side effects, and cost. Most drugs have other uses; sometimes the presence of other symptoms can warrant the use of one particular antihypertensive. Examples include: Age can affect the choice of medications.
The contents of this page have been copied to Talk:List_of_drugs. Please put comments there. I (User:MattKingston) am in the process of creating a list of drugs and their various names. The list will be alphabetical and will use the following format (subject to change if better suggestions are put forward).
Antiplatelet drugs effect may be affected by patient's medications, current medical conditions, food and supplements taken. Antiplatelet drugs effect may be increased or decreased. An increase in antiplatelet effect would increase the risk of bleeding and could cause prolonged or excessive bleeding.
Pulmonary alveolar proteinosis; Pulmonary arterial hypertension; Pulmonary aspiration; Pulmonary capillary hemangiomatosis; Pulmonary contusion; Pulmonary fibrosis; Pulmonary hematoma; Pulmonary hemorrhage; Pulmonary hyperplasia; Pulmonary laceration; Pulmonary oxygen toxicity; Pulmonary toxicity; Pulmonary venoocclusive disease; Pulmonary ...
An endothelin receptor antagonist (ERA) is a drug that blocks endothelin receptors. Three main kinds of ERAs exist: Dual ET Receptor Antagonists, which affect both endothelin A (ET A) and B receptors (ET B) [1] aprocitentan, bosentan, macitentan, tezosentan; Selective ET A Receptor Antagonists, which affect endothelin A receptors